Association of KDR rs1870377 genotype with clopidogrel resistance in patients with post percutaneous coronary intervention
W Al Awaida, AA Ahmed, AA Hamza, KI Amber… - Heliyon, 2021 - cell.com
Background Clopidogrel is an antiplatelet therapy that is widely used in pre and post
percutaneous (PCI) coronary intervention procedures to prevent platelet aggregation and …
percutaneous (PCI) coronary intervention procedures to prevent platelet aggregation and …
CYP2C19* 2 polymorphism and clopidogrel resistance
B Joob, V Wiwanitkit - Archivos de cardiología de México, 2020 - scielo.org.mx
CYP2C19* 2 allele is related to resistance to the antiplatelet effect of CLO” 1. Indeed, the
CYP2C19* 2 polymorphism can result in molecular change, and this can further result in …
CYP2C19* 2 polymorphism can result in molecular change, and this can further result in …
Influence of CYP2C19* 2 Polymorphism on Clinical Outcomes in Moldova's Patients Treated with Clopidogrel After Percutaneous Coronary Intervention
M Dogot, D Galea-Abdusa, A Buza, A Grib… - International Conference …, 2023 - Springer
Clopidogrel is one of the most commonly antiplatelet agents used for the secondary
prevention of atherothrombotic events in patients with cardiovascular disease (CVD) …
prevention of atherothrombotic events in patients with cardiovascular disease (CVD) …
CYP2C19 基因多态性与急性心肌梗死患者炎症指标, 临床预后的相关性
吴天源， 罗义， 吕磊， 谭文亮， 孙少喜 - 广州医药, 2022 - gzyyzz.cn
目的探讨急性心肌梗死患者细胞色素P450 酶基因(cytochrome P450, family 2, subfamily C,
polypeptide 19, CYP2C19) 多态性与高敏C-反应蛋白(hypersensitive C-reactive protein, hs …
polypeptide 19, CYP2C19) 多态性与高敏C-反应蛋白(hypersensitive C-reactive protein, hs …
[PDF][PDF] The correlation between platelet responsiveness to clopidogrel and CYP2C19 polymorphism in patients with peripheral vascular disease.
NM El-Khodary, AM El-Behery… - European Review for …, 2021 - europeanreview.org
OBJECTIVE: Several patients undergoing endovascular intervention and bypass surgery
present with high platelet reactivity following clopidogrel treatment. We aimed to determine …
present with high platelet reactivity following clopidogrel treatment. We aimed to determine …
[PDF][PDF] RIESGO CARDIOVASCULAR Y COMPONENTES DEL SÍNDROME METABÓLICO EN DERECHOHABIENTES DE LA UMF 69.
DRAFA GONZALEZ - 2023 - ru.dgb.unam.mx
Antecedentes: En los últimos años la enfermedad cardiovascular ha desplazado a las
infecciones como primera causa de mortalidad. Se diseñaron para estimar el riesgo …
infecciones como primera causa de mortalidad. Se diseñaron para estimar el riesgo …
[PDF][PDF] MI, USA 3Department of Biomedical Data Science, Stanford University, Stanford, CA, USA 4Department of Pharmacy Practice, Massachusetts College of …
Yi, et al.(2018)(110) Tomek, et al.(2018)(108) Li, et al.(2019)(159) Akram, et al.(2019)(114)
Feng, et al.(2019)(160) Lyerly, et al.(2019)(161) Tanaka, et al.(2019)(162) Tan, et …
Feng, et al.(2019)(160) Lyerly, et al.(2019)(161) Tanaka, et al.(2019)(162) Tan, et …
Genotyping single-nucleotide polymorphism CYP2C19* 2, pharmacodynamic evaluation of high on-clopidogrel treatment platelet reactivity and the cardiologist
CF Barrera-Ramírez, LR Pineda-Pompa… - … de cardiología de …, 2020 - scielo.org.mx
Sir, we have read with interest Cedillo-Salazar et al. report 1 and we believe pertinent make
some comments. Effectiveness of clopidogrel depends on its conversion to an active …
some comments. Effectiveness of clopidogrel depends on its conversion to an active …
The Effect of Waterpipe/Hookah on Platelet Function and the Impact of Inhibition of Gβγ Subunits on Hemostasis and Thrombogenesis
AB Alarabi - 2020 - search.proquest.com
Cardiovascular diseases (CVD's) is a major public health problem. Among CVD's risk
factors, tobacco smoking is considered the single most preventable cause of death, with …
factors, tobacco smoking is considered the single most preventable cause of death, with …